Get startedLog in
    Picture of Apogee Therapeutics logo

    APGE — Apogee Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Apogee Therapeutics Inc - Blackstone Life Sciences To Pay $100 Million Upfront For Revenue Share On Zumilokibart Sales - SEC Filing

    Picture of Apogee Therapeutics logoApogee Therapeutics
    27/05/2026 14:26
    BRIEF-Apogee Therapeutics Inc - Blackstone Life Sciences  To Pay $100 Million Upfront For Revenue Share On Zumilokibart Sales - SEC Filing
    May 27 (Reuters) - SEC Filing:
    • APOGEE THERAPEUTICS INC - BLACKSTONE LIFE SCIENCES  TO PAY $100 MILLION UPFRONT FOR REVENUE SHARE ON ZUMILOKIBART SALES - SEC FILING
    • APOGEE THERAPEUTICS INC - TRANCHE 4 REVENUE SHARE PAYMENTS TO BLACKSTONE LIFE SCIENCES CAPPED AT $1 BILLION - SEC FILING
    Source text: [ID:n0001104659-26-066575]
    Further company coverage: APGE.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Apogee Therapeutics

    See all news